Matches in Nanopublications for { ?s ?p "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP201265.RA5WYteuYZABgixstnPcHaY1g76Kmll3ZVCR-YOmXLOf0130_assertion description "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201265.RA5WYteuYZABgixstnPcHaY1g76Kmll3ZVCR-YOmXLOf0130_provenance.
- assertion description "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion description "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_provenance.
- NP247227.RAGhTxl18lWyfrfUyV5IeMuvD9JmhvcryctHy6pp2nTOQ130_assertion description "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247227.RAGhTxl18lWyfrfUyV5IeMuvD9JmhvcryctHy6pp2nTOQ130_provenance.